Walleye Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-35,290
| Closed | -$322K | – | 5053 |
|
|
2025
Q2 | $322K | Buy |
35,290
+23,343
| +195% | +$172K | ﹤0.01% | 2992 |
|
|
2025
Q1 | $95K | Sell |
11,947
-44,126
| -79% | -$323K | ﹤0.01% | 3650 |
|
|
2024
Q4 | $304K | Sell |
56,073
-164,900
| -75% | -$1.01M | ﹤0.01% | 3412 |
|
|
2024
Q3 | $1.6M | Buy |
220,973
+92,229
| +72% | +$844K | ﹤0.01% | 2190 |
|
|
2024
Q2 | $1.4M | Buy |
128,744
+62,428
| +94% | +$800K | ﹤0.01% | 2484 |
|
|
2024
Q1 | $1.24M | Sell |
66,316
-3,443
| -5% | -$79.4K | ﹤0.01% | 2378 |
|
|
2023
Q4 | $1.51M | Buy |
+69,759
| New | +$1.38M | ﹤0.01% | 2005 |
|
|
2023
Q3 | – | Sell |
-54,561
| Closed | -$1.58M | – | 5271 |
|
|
2023
Q2 | $2.57M | Buy |
+54,561
| New | +$2.71M | 0.01% | 1167 |
|
|
2022
Q3 | – | Sell |
-33,199
| Closed | -$1.28M | – | 3495 |
|
|
2022
Q2 | $1.07M | Buy |
+33,199
| New | +$1.11M | 0.03% | 615 |
|
|
2022
Q1 | – | Sell |
-75,679
| Closed | -$3.22M | – | 2557 |
|
|
2021
Q4 | $3.22M | Buy |
+75,679
| New | +$3.17M | 0.1% | 225 |
|
|
2020
Q2 | – | Sell |
-18,445
| Closed | -$530K | – | 921 |
|
|
2020
Q1 | $530K | Buy |
+18,445
| New | +$1.07M | 0.12% | 217 |
|
|
2019
Q4 | – | Sell |
-9,199
| Closed | -$1.29M | – | 2204 |
|
|
2019
Q3 | $1.29M | Buy |
+9,199
| New | +$1.54M | 0.08% | 351 |
|
Other funds holding SAGE
IA
HNB